Season 5, Episode 2 - Are 30% of the global population sick? A critical view on Steatotic Liver Disease and care pathways
Thirty percent of the global population have too much fat in their liver. The big question is: are they really sick when most will not end up with liver disease?
This episode will discuss:
- How should they be assessed and by whom?
- What does this mean to healthcare systems?
- Are there downsides to systematic screening?
Faculty: Aleksander Krag (Moderator), Alina Allen (Faculty), Manal El-Sayed (Faculty), Ian Rowe (Faculty)
Related episode: EASL Studio Live from EASL Congress 2023: Steatotic liver disease global consensus to change nomenclature
This EASL Studio is supported by an educational grant from NOVO NORDISK A/S.
ℹ The episode will be broadcasted live on this page.
